Benzothiazol-2-yl-(tetrahydro-furan-2-ylmethyl)-amine, 95.0%, 2.5g

Cyclohexane-1,2,3,4,5,6-hexacarboxylic acid, 98%, 25g

CETILISTAT, 95%, 1g

1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborlan-2-yl-)-1H-pyrazole, 98.0%, 10g

5-Nitro-2-(trifluoromethyl)pyridin-4-amine, 95.0%, 100mg

Phase contrast Abbe condenser with slide for Plan PLPHi S40 phase contrast infinity corrected objectives, slide with 40x phasing, telescope and green filter

5,6,7,8-Tetrahydro-naphthalene-2-carbaldehyde, 95.0%, 1g

4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid, 95.0%, 25g

5,6,7,8-Tetrahydro-2-naphthalenylboronic acid, 98%, 250mg

4-Nitro-3-(trifluoromethyl)benzaldehyde, 95.0%, 1g

tert-Butyl ((6-bromopyridin-2-yl)methyl)carbamate, 95.0%, 5g

4-Thiophen-3-yl-benzoic acid, 95.0%, 5g

2-(Trifluoromethyl)pyrrolidine hydrochloride, 97%, 10g